Mineralys Therapeutics, Inc. (MLYS) Stock Price History
Historical prices from 2023 to 2026
Loading 10-year price history...
Historical Performance
Short-Term Returns
MLYS Stock Price Trajectory (2023–2026)
As of March 2, 2026, Mineralys Therapeutics, Inc. (MLYS) trades at $29.26, representing a +220.1% return over the past year. The stock has delivered a +9.7% return over five years, reflecting significant long-term value creation.
The stock reached its all-time high of $47.65 on November 12, 2025. From this peak, MLYS has corrected -38.6%, currently trading 3% above its 200-day moving average, indicating continued institutional support.
When compared to Healthcare sector peers UTHR (+57.4% 1Y), ZLAB (-44.5% 1Y), and AMRN (+27.3% 1Y), MLYS has outperformed the peer group average. Compare MLYS vs UTHR →
Historical Price Data
Showing 30 of 733 records| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-02-27 | 28.45 | 29.35 | 28.27 | 29.26 | 29 | +0.79% |
| 2026-02-26 | 29.11 | 29.15 | 28.13 | 29.03 | 29 | -0.68% |
| 2026-02-25 | 29.96 | 29.97 | 28.54 | 29.23 | 29 | -2.44% |
| 2026-02-24 | 28.61 | 30.05 | 27.76 | 29.96 | 29 | +3.56% |
| 2026-02-23 | 28.16 | 29.53 | 27.83 | 28.93 | 28 | +3.77% |
| 2026-02-20 | 27.84 | 28.25 | 27.38 | 27.88 | 27 | -0.64% |
| 2026-02-19 | 27.75 | 28.20 | 26.85 | 28.06 | 1.62M | +0.43% |
| 2026-02-18 | 27.89 | 28.64 | 27.61 | 27.94 | 628K | -1.59% |
| 2026-02-17 | 27.59 | 28.39 | 27.29 | 28.39 | 32K | +2.86% |
| 2026-02-13 | 27.33 | 28.65 | 27.33 | 27.60 | 1.07M | -0.93% |
| 2026-02-12 | 29.42 | 29.69 | 27.80 | 27.86 | 1.32M | -6.45% |
| 2026-02-11 | 31.04 | 31.12 | 28.79 | 29.78 | 1.79M | -4.15% |
| 2026-02-10 | 31.86 | 32.21 | 30.90 | 31.07 | 1.10M | -2.11% |
| 2026-02-09 | 30.21 | 31.84 | 30.21 | 31.74 | 1.31M | +6.62% |
| 2026-02-06 | 28.98 | 30.19 | 28.42 | 29.77 | 1.56M | +5.53% |
| 2026-02-05 | 30.78 | 31.41 | 28.17 | 28.21 | 1.18M | -7.87% |
| 2026-02-04 | 31.78 | 31.83 | 30.33 | 30.62 | 1.08M | -2.98% |
| 2026-02-03 | 30.89 | 31.70 | 30.34 | 31.56 | 1.83M | +2.24% |
| 2026-02-02 | 30.89 | 31.40 | 30.37 | 30.87 | 785K | -0.06% |
| 2026-01-30 | 31.83 | 32.34 | 30.79 | 30.89 | 894K | -3.74% |
| 2026-01-29 | 32.21 | 32.55 | 31.57 | 32.09 | 526K | -0.77% |
| 2026-01-28 | 32.71 | 32.99 | 31.81 | 32.34 | 690K | -1.52% |
| 2026-01-27 | 33.00 | 33.63 | 32.25 | 32.84 | 669K | -0.61% |
| 2026-01-26 | 32.78 | 33.26 | 32.05 | 33.04 | 683K | +0.79% |
| 2026-01-24 | 33.84 | 34.22 | 32.26 | 32.78 | 1.14M | 0.00% |
| 2026-01-23 | 33.84 | 34.22 | 32.26 | 32.78 | 1.16M | -4.38% |
| 2026-01-22 | 31.29 | 34.65 | 31.23 | 34.28 | 1.44M | +9.49% |
| 2026-01-21 | 31.43 | 31.86 | 30.96 | 31.31 | 940K | -1.94% |
| 2026-01-20 | 32.10 | 32.93 | 31.59 | 31.93 | 1.17M | -2.47% |
| 2026-01-16 | 31.38 | 32.97 | 31.08 | 32.74 | 1.38M | +4.33% |
See MLYS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MLYS Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare MLYS vs AGIO
See how MLYS stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
How has MLYS stock performed recently?
MLYS returned +220.1% over the past year, beating its 5-year annualized CAGR of +9.7%. The stock trades above its 200-day moving average, confirming the uptrend.
What is MLYS's all-time high price?
Mineralys Therapeutics, Inc. reached $47.65 on 2025-11-12. The 52-week high is $47.65. Current 1-year return of +220.1% places the stock closer to historical peaks.
Where can I download MLYS historical price data?
This page provides MLYS daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2023-2026, downloadable in CSV format.